Table 1.
ID | assay name | assay source | gene name | time point (min) |
biological process target | assay design type | cell line | ER KE | vAOP model layer |
---|---|---|---|---|---|---|---|---|---|
E1 | NVS_NR_hER | NovaScreen | ESR1 | 1080 | receptor binding | radioligand binding | NA (cell-free) | ER binding | 2 |
E2 | OT_ER_ERaERa_0480 | Odyssey Thera | ESR1 | 480 | protein stabilization | protein fragment complementation assay | HEK293T | receptor dimerization | 3 |
E3 | OT_ER_ERaERa_1440 | Odyssey Thera | ESR1 | 1440 | protein stabilization | protein fragment complementation assay | HEK293T | receptor dimerization | 3 |
E4 | OT_ER_ERaERb_0480 | Odyssey Thera | ESR1, ESR2 | 480 | protein stabilization | protein fragment complementation assay | HEK293T | receptor dimerization | 3 |
E5 | OT_ER_ERaERb_1440 | Odyssey Thera | ESR1, ESR2 | 1440 | protein stabilization | protein fragment complementation assay | HEK293T | receptor dimerization | 3 |
E6 | OT_ER_ERbERb_0480 | Odyssey Thera | ESR2 | 480 | protein stabilization | protein fragment complementation assay | HEK293T | receptor dimerization | 3 |
E7 | OT_ER_ERbERb_1440 | Odyssey Thera | ESR2 | 1440 | protein stabilization | protein fragment complementation assay | HEK293T | receptor dimerization | 3 |
E8 | OT_ERa_EREGFP_0120 | Odyssey Thera | ESR1 | 120 | regulation of gene expression | fluorescent protein induction | HeLa | DNA binding | 4 |
E9 | OT_ERa_EREGFP_0480 | Odyssey Thera | ESR1 | 480 | regulation of gene expression | fluorescent protein induction | HeLa | DNA binding | 4 |
E10 | ATG_ERa_TRANS_up | Attagene, Inc. | ESR1 | 1440 | regulation of transcription factor activity | mRNA induction | HepG2 | transcriptional activation | 5 |
E11 | ATG_ERE_CIS_up | Attagene, Inc. | ESR1 | 1440 | regulation of transcription factor activity | mRNA induction | HepG2 | transcriptional activation | 5 |
E12 | TOX21_ERa_BLA_Agonist_ratio | Tox21 | ESR1 | 1440 | egulation of transcription factor activity | β lactamase induction | HEK293T | transcriptional activation | 5 |
E13 | TOX21_ERa_LUC_VM7_Agonist | Tox21 | ESR1 | 1320 | regulation of transcription factor activity | luciferase induction | VM7 | transcriptional activation | 5 |
E14 | ACEA_ER_80hr | ACEA Biosciences, Inc. | ESR1 | 1920 | cell proliferation | real-time cell-growth kinetics | T47D | cell proliferation | 6 |
NA: not applicable.